Dr. Michael Kennelly, MD
NPI: 1720021637
Total Payments
$1.4M
2024 Payments
$218,030
Companies
39
Transactions
1,822
Medicare Patients
8,040
Medicare Billing
$759,373
Payment Breakdown by Category
Other$734,915 (51.1%)
Consulting$468,352 (32.6%)
Travel$169,449 (11.8%)
Food & Beverage$47,182 (3.3%)
Education$13,678 (1.0%)
Research$5,121 (0.4%)
Gifts$74.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $734,234 | 287 | 51.0% |
| Consulting Fee | $468,352 | 169 | 32.6% |
| Travel and Lodging | $169,449 | 590 | 11.8% |
| Food and Beverage | $47,182 | 756 | 3.3% |
| Education | $13,678 | 12 | 1.0% |
| Unspecified | $5,121 | 4 | 0.4% |
| Honoraria | $680.90 | 3 | 0.0% |
| Gift | $74.89 | 1 | 0.0% |
Payments by Type
General
$1.4M
1,818 transactions
Research
$5,121
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $265,671 | 339 | $0 (2022) |
| Boston Scientific Corporation | $243,677 | 325 | $0 (2024) |
| ABBVIE INC. | $231,902 | 227 | $0 (2024) |
| COLOPLAST CORP | $182,887 | 101 | $0 (2024) |
| Medtronic, Inc. | $126,958 | 222 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $79,369 | 106 | $0 (2024) |
| Astellas Pharma US Inc | $75,927 | 86 | $0 (2023) |
| Axonics, Inc. | $68,562 | 98 | $0 (2024) |
| UROVANT SCIENCES INC | $66,484 | 105 | $0 (2022) |
| C. R. Bard, Inc. & Subsidiaries | $32,824 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $218,030 | 250 | ABBVIE INC. ($98,502) |
| 2023 | $214,558 | 301 | ABBVIE INC. ($87,492) |
| 2022 | $262,652 | 303 | Medtronic, Inc. ($69,378) |
| 2021 | $134,606 | 198 | Allergan, Inc. ($53,030) |
| 2020 | $86,858 | 99 | Allergan, Inc. ($52,101) |
| 2019 | $167,910 | 238 | Boston Scientific Corporation ($95,823) |
| 2018 | $190,895 | 226 | BOSTON SCIENTIFIC CORPORATION ($66,168) |
| 2017 | $163,261 | 207 | Allergan Inc. ($83,591) |
All Payment Transactions
1,822 individual payment records from CMS Open Payments — Page 73 of 73
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/28/2017 | Allergan Inc. | BOTOX OAB (Drug) | Food and Beverage | In-kind items and services | $51.90 | General |
| Category: OVER ACTIVE BLADDER | ||||||
| 02/28/2017 | Allergan Inc. | BOTOX OAB (Drug) | Food and Beverage | In-kind items and services | $47.67 | General |
| Category: OVER ACTIVE BLADDER | ||||||
| 02/28/2017 | Allergan Inc. | BOTOX OAB (Drug) | Food and Beverage | In-kind items and services | $45.41 | General |
| Category: OVER ACTIVE BLADDER | ||||||
| 02/28/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: Urology | ||||||
| 02/22/2017 | BOSTON SCIENTIFIC CORPORATION | UPHOLD LITE VAGINAL SUPPORT SYSTEM (Device) | Food and Beverage | In-kind items and services | $119.90 | General |
| Category: PELVIC ORGAN PROLAPSE | ||||||
| 02/21/2017 | NeoTract Inc. | Urolift - UL400 (Device) | Travel and Lodging | Cash or cash equivalent | $27.78 | General |
| Category: Urology | ||||||
| 02/17/2017 | BOSTON SCIENTIFIC CORPORATION | SOLYX SIS SYSTEM (Device) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: PELVIC ORGAN PROLAPSE | ||||||
| 02/15/2017 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $80.34 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 02/14/2017 | BOSTON SCIENTIFIC CORPORATION | SOLYX (Device) | Travel and Lodging | In-kind items and services | $806.90 | General |
| Category: PELVIC ORGAN PROLAPSE | ||||||
| 02/06/2017 | BOSTON SCIENTIFIC CORPORATION | POLARIS ULTRA URETERAL STENT (Device) | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: URETERAL STENTS AND GUIDEWIRES | ||||||
| 02/01/2017 | Allergan Inc. | BOTOX OAB (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: OVER ACTIVE BLADDER | ||||||
| 01/31/2017 | Allergan Inc. | BOTOX NDO (Drug) | Food and Beverage | In-kind items and services | $114.70 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2017 | Allergan Inc. | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 01/26/2017 | Medtronic USA, Inc. | INTERSTIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 01/23/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: Urology | ||||||
| 01/17/2017 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $85.20 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 01/17/2017 | BOSTON SCIENTIFIC CORPORATION | SOLYX SIS SYSTEM (Device) | Food and Beverage | In-kind items and services | $4.63 | General |
| Category: PELVIC ORGAN PROLAPSE | ||||||
| 01/13/2017 | BOSTON SCIENTIFIC CORPORATION | PERCUFLEX STENTS (Device) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: URETERAL STENTS AND GUIDEWIRES | ||||||
| 01/12/2017 | Allergan Inc. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| 01/11/2017 | Medtronic USA, Inc. | NURO (Device) | Food and Beverage | In-kind items and services | $99.24 | General |
| Category: Tibial Nerve Stimulation | ||||||
| 01/05/2017 | Cogentix Medical Inc. | Urgent PC (Device), Macroplastique, PrimeSight | Food and Beverage | Cash or cash equivalent | $72.35 | General |
| Category: Urology | ||||||
| 01/04/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: Urology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ROBUST III | Urotronic, Inc | $2,538 | 1 |
| TITAN 2 | Medtronic, Inc. | $2,096 | 2 |
| A TWO-PART, MULTICENTER, DOSE-TITRATION STUDY EVALUATING THE EFFICACY, SAFETY, PHARMACODYNAMICS, AND PHARMACOKINETICS OF OXYBUTYNINCHLORIDE 10 GEL FOR THE TREATMENT OF DETRUSOR OVERACTIVITY ASSOCIATED WITH A NEUROLOGICAL CONDITION IN PEDIATRIC PATIENTS | Allergan Inc. | $487.52 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,454 | 12,589 | $1.5M | $205,732 |
| 2022 | 25 | 2,184 | 12,311 | $1.5M | $217,433 |
| 2021 | 29 | 1,792 | 10,659 | $1.1M | $197,012 |
| 2020 | 22 | 1,610 | 8,434 | $778,562 | $139,196 |
Total Patients
8,040
Total Services
43,993
Medicare Billing
$759,373
Procedure Codes
126
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 52 | 9,730 | $223,790 | $47,849 | 21.4% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 52 | 80 | $122,080 | $22,577 | 18.5% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Facility | 2023 | 178 | 178 | $86,864 | $16,777 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 168 | 217 | $47,740 | $14,423 | 30.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 61 | 74 | $69,782 | $12,349 | 17.7% |
| 64561 | Insertion of sacral nerve neurostimulator electrode array | Office | 2023 | 13 | 13 | $60,576 | $10,275 | 17.0% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Facility | 2023 | 115 | 116 | $46,748 | $8,784 | 18.8% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Facility | 2023 | 294 | 295 | $89,090 | $8,739 | 9.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 95 | $29,450 | $8,735 | 29.7% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Facility | 2023 | 52 | 85 | $129,710 | $8,451 | 6.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 71 | 85 | $26,350 | $5,652 | 21.4% |
| 64561 | Insertion of sacral nerve neurostimulator electrode array | Facility | 2023 | 24 | 24 | $90,864 | $5,549 | 6.1% |
| 51705 | Simple change of bladder tube | Facility | 2023 | 29 | 137 | $62,198 | $4,731 | 7.6% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Facility | 2023 | 293 | 294 | $85,848 | $4,129 | 4.8% |
| 51705 | Simple change of bladder tube | Office | 2023 | 12 | 60 | $27,240 | $3,902 | 14.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $10,238 | $3,188 | 31.1% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 56 | 87 | $25,839 | $2,564 | 9.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 31 | 40 | $8,772 | $2,362 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 39 | 42 | $9,240 | $2,049 | 22.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 44 | 46 | $6,256 | $1,910 | 30.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 30 | 33 | $31,119 | $1,693 | 5.4% |
| 64590 | Insertion of peripheral or gastric neurostimulator generator | Facility | 2023 | 23 | 23 | $30,406 | $1,535 | 5.0% |
| 95971 | Electronic analysis of implanted neurostimulator generator with simple spinal cord or peripheral nerve stimulator programming | Office | 2023 | 30 | 38 | $6,536 | $1,369 | 20.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $4,256 | $1,121 | 26.3% |
| 76000 | Imaging guidance for procedure, 60 minutes or less | Facility | 2023 | 87 | 87 | $4,698 | $1,009 | 21.5% |
About Dr. Michael Kennelly, MD
Dr. Michael Kennelly, MD is a Urogynecology and Reconstructive Pelvic Surgery healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720021637.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Kennelly, MD has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $218,030 received in 2024. These payments were reported across 1,822 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($734,234).
As a Medicare-enrolled provider, Kennelly has provided services to 8,040 Medicare beneficiaries, totaling 43,993 services with total Medicare billing of $759,373. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Ad
Practice Information
- Specialty Urogynecology and Reconstructive Pelvic Surgery
- Other Specialties Urology
- Location Charlotte, NC
- Active Since 06/14/2006
- Last Updated 07/15/2024
- Taxonomy Code 2088F0040X
- Entity Type Individual
- NPI Number 1720021637
Products in Payments
- BOTOX (Biological) $418,494
- GEMTESA (Drug) $138,333
- INTERSTIM (Device) $128,015
- SPEEDICATH (Device) $69,750
- SpeediCath (Device) $51,539
- SOLYX (Device) $39,649
- Luja Coude (Device) $36,953
- Axonics (Device) $35,894
- BOTOX (Drug) $34,003
- MYRBETRIQ (Drug) $32,562
- Myrbetriq (Drug) $30,077
- XENFORM (Device) $29,181
- Axonics r-SNM System (Device) $27,551
- GENERAL FEMALE SUI (Device) $24,825
- GENERAL - PELVIC ORGAN PROLAPSE (Device) $23,765
- GENERAL PELVIC ORGAN PROLAPSE (Device) $17,461
- BOTOX OAB (Drug) $14,252
- GENERAL THERAPIES (Device) $13,682
- AMS (Device) $13,405
- ADVANCE (Device) $13,298
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.